Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predicting the risk of cystic fibrosis with echogenic fetal bowel and one cystic fibrosis mutation.

Obstetrics and gynecology - 1 Dec 1999

Bosco A F, Norton M E, Lieberman E

Abstract excerpt

OBJECTIVE: To assess fetal risk for cystic fibrosis when echogenic bowel and one cystic fibrosis mutation are detected. METHODS: A hypothetical cohort of 1000 women with singleton pregnancies and echogenic fetal bowel during the second trimester was used to determine the probability of cystic fibrosis when one cystic fibrosis transmembrane conductance regulator mutation was detected. The risk of cystic fibrosis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystic Fibrosis
Share to Cystic Fibrosis Transmembrane Conductance Regulator

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Counseling

Share to Intestines

Share to Predictive Value of Tests

Share to Pregnancy Trimester, Second

Share to Risk Assessment

Share to Ultrasonography

Source

Identifiers

PMID: 10576193
DOI: 10.1016/s0029-7844(99)00443-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predicting the risk of cystic fibrosis with echogenic fetal bowel and one cystic fibrosis mutation.PMID 10576193Read ↗

The risk of cystic fibrosis with prenatally detected echogenic bowel in an ethnically and racially diverse North American population.Semantic proximity Read ↗

Calculating posterior cystic fibrosis risk with echogenic bowel and one characterized cystic fibrosis mutation: avoiding pitfalls in the risk calculations.Semantic proximity Read ↗

Predicting the risk of cystic fibrosis with abnormal ultrasound signs of fetal bowel: results of a French molecular collaborative study based on 641 prospective cases.Semantic proximity Read ↗

Cystic fibrosis and chromosome abnormalities associated with echogenic fetal bowel.Semantic proximity Read ↗

Bayesian risk assessment for autosomal recessive diseases: fetal echogenic bowel with one or no detectable CFTR mutation.Semantic proximity Read ↗

Prevalence of cystic fibrosis mutations in pregnancies with fetal echogenic bowel.Semantic proximity Read ↗

Cystic fibrosis screening: a fetus with hyperechogenic bowel may be the index case.Semantic proximity Read ↗

Bayesian analysis for cystic fibrosis risks in prenatal and carrier screening.Semantic proximity Read ↗

Is testing for cytomegalovirus and cystic fibrosis indicated in members of a nonwhite pregnant population in whom the fetus has an echogenic bowel?Semantic proximity Read ↗

The clinical significance of fetal echogenic bowel.Semantic proximity Read ↗

Hyperechogenic fetal bowel: a large French collaborative study of 682 cases.Semantic proximity Read ↗

Incidence of chromosomopathies and cystic fibrosis mutations in second trimester fetuses with isolated hyperechoic bowel.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.